Sector
PharmaceuticalsOpen
₹260Prev. Close
₹261.5Turnover(Lac.)
₹2.13Day's High
₹268.75Day's Low
₹26052 Week's High
₹417.8552 Week's Low
₹241Book Value
₹117.08Face Value
₹10Mkt Cap (₹ Cr.)
150.94P/E
16.28EPS
16.1Divi. Yield
1.72Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 5.76 | 5.76 | 5.76 | 5.94 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 56.4 | 48.94 | 42.83 | 37.13 |
Net Worth | 62.16 | 54.7 | 48.59 | 43.07 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Revenue | 69.39 | 57.45 | 59.47 | 41.01 |
yoy growth (%) | 20.78 | -3.4 | 45.02 | -6.1 |
Raw materials | -48.97 | -37.18 | -36.15 | -24.04 |
As % of sales | 70.57 | 64.71 | 60.78 | 58.62 |
Employee costs | -6.61 | -6.25 | -7.49 | -6.25 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 9.1 | 8.74 | 8.12 | 5.17 |
Depreciation | -0.63 | -0.78 | -0.96 | -0.75 |
Tax paid | -2.33 | -2.38 | -2.17 | -1.41 |
Working capital | -0.33 | 4.99 | 9.66 | 1.37 |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 20.78 | -3.4 | 45.02 | -6.1 |
Op profit growth | 6.64 | -5.14 | 67.27 | 11.67 |
EBIT growth | 3.34 | 2.47 | 62.25 | 1.81 |
Net profit growth | 13.58 | 7.01 | 57.84 | 12.83 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairperson & Managing Direct
Jayashree Nair
Joint Managing Director & CFO
S C Kachhara
Non Executive Director
Karthika Nair
Company Sec. & Compli. Officer
Nikita Phatak
Independent Director
Prabhakar Dalal
Independent Director
Mitul Patel
Independent Director
Suresh Chandra Kookada
Nair Baug,
Akurli Road Kandivli (E),
Maharashtra - 400101
Tel: 91-22-28871370/28870834
Website: http://www.bdhind.com
Email: comp.sec@bdhind.com
C-101 1st Floor,
247 Park Vikhroli W, Lal Bahadur Marg,
Mumbai - 400 083
Tel: -
Website: www.tsrdarashaw.com
Email: csg-unit@tsrdarashaw.com
Summary
Incorporated in 1990 as a private limited company, BDH Industries (BDHIL) was converted into a public limited company in 1994. It was established to take over a going concern, Bombay Drug House Pvt Lt...
Read More
Reports by BDH Industries Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.